News
10-13-2015, 12:56 AM
A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania.
More... (http://www.news-medical.net/news/20151013/Research3b-Epigenetic-factor-reduces-sensitivity-of-breast-cancer-cells-to-common-cancer-drug.aspx)
More... (http://www.news-medical.net/news/20151013/Research3b-Epigenetic-factor-reduces-sensitivity-of-breast-cancer-cells-to-common-cancer-drug.aspx)